Literature DB >> 18396044

Phenotype and clinical course in a family with a new de novo Twinkle gene mutation.

Tina D Jeppesen1, Marianne Schwartz, Eskild Colding-Jørgensen, Thomas Krag, Simon Hauerslev, John Vissing.   

Abstract

The Twinkle gene product is important for mtDNA replication. Only a few reports have investigated the clinically effect of mutations in this gene. We describe a new de novo mutation (1110C>A) in the PEO1 gene in a mother and her two sons. The mother had progressive ophthalmoplegia, limb weakness, sensory neuropathy, elevated resting plasma lactate, glucose intolerance and impaired VO2max while her sons only had mild ptosis. In accordance with the clinical presentation, abnormal morphological findings in muscle and multiple deletions and depletion of mtDNA in muscle were more pronounced in the proband than in her sons.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18396044     DOI: 10.1016/j.nmd.2007.10.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  4 in total

1.  A novel variation in the Twinkle linker region causing late-onset dementia.

Authors:  Andoni Echaniz-Laguna; Jean-Baptiste Chanson; Jean-Marie Wilhelm; François Sellal; Martine Mayençon; Michel Mohr; Christine Tranchant; Bénédicte Mousson de Camaret
Journal:  Neurogenetics       Date:  2009-06-10       Impact factor: 2.660

Review 2.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

3.  Twinkle mutations in two Chinese families with autosomal dominant progressive external ophthalmoplegia.

Authors:  Kunqian Ji; Kaiming Liu; Pengfei Lin; Bing Wen; Yue-Bei Luo; Yuying Zhao; Chuanzhu Yan
Journal:  Neurol Sci       Date:  2013-10-04       Impact factor: 3.307

4.  The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO.

Authors:  C Fratter; G S Gorman; J D Stewart; M Buddles; C Smith; J Evans; A Seller; J Poulton; M Roberts; M G Hanna; S Rahman; S E Omer; T Klopstock; B Schoser; C Kornblum; B Czermin; B Lecky; E L Blakely; K Craig; P F Chinnery; D M Turnbull; R Horvath; R W Taylor
Journal:  Neurology       Date:  2010-05-18       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.